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Upon prolonged exposure to cholate and other toxic compounds, Lactococcus lactis develops a multidrug
resistance phenotype that has been attributed to an elevated expression of the heterodimeric ABC-type
multidrug transporter LmrCD. To investigate the molecular basis of bile acid resistance in L. lactis and to
evaluate the contribution of efflux-based mechanisms in this process, the drug-sensitive L. lactis NZ9000
lmrCD strain was challenged with cholate. A resistant strain was obtained that, compared to the parental
strain, showed (i) significantly improved resistance toward several bile acids but not to drugs, (ii) morpho-
logical changes, and (iii) an altered susceptibility to antimicrobial peptides. Transcriptome and transport
analyses suggest that the acquired resistance is unrelated to elevated transport activity but, instead, results
from a multitude of stress responses, changes to the cell envelope, and metabolic changes. In contrast,
wild-type cells induce the expression of lmrCD upon exposure to cholate, whereupon the cholate is actively
extruded from the cells. Together, these data suggest a central role for an efflux-based mechanism in bile acid
resistance and implicate LmrCD as the main system responsible in L. lactis.
Multidrug transporters are responsible for active efflux of
structurally and functionally unrelated drugs and are ubiqui-
tous in nature (21, 32). The majority of the described multidrug
transporters in bacteria depend on ion motive forces for ex-
trusion activity, while only few systems use ATP hydrolysis to
drive efflux. However, recent reports and functional genomic
predictions suggest that the role of these bacterial ABC-type
transporters in multidrug resistance (MDR) might be under-
estimated (32).
Lactococcus lactis is a nonpathogenic lactic acid bacterium
that serves as a model organism to study bacterial MDR (31).
The genome of L. lactis contains 40 putative drug transporter
genes of which several have been characterized in detail. These
are LmrP (8), a member of the major facilitator superfamily
(MFS) transporter, and the ABC-type transporters LmrA (48)
and LmrCD (31). L. lactis MG1363 readily acquires a stable
MDR phenotype when challenged with increasing concentra-
tions of cholate (51) or other drugs (7). An ATP-dependent
transporter has been implicated in cholate resistance, but its
identity has remained obscure (51). Recent transcriptome
analysis revealed that a common response of the selected
MDR strains is the elevated expression of lmrCD compared to
the wild-type strain (31). Furthermore, the deletion of the
lmrCD genes makes L. lactis more susceptible to a wide range
of toxic compounds, while the drug resistance phenotype can
be restored by the overexpression of lmrCD from a plasmid
(33).
Although previous studies implicated LmrCD as a major
determinant of drug resistance in L. lactis, it has remained
unclear whether other putative MDR transporters contribute
to resistance in the selected strains as the observed phenotype
covers both anionic and cationic drugs such as daunomycin,
rhodamine, and ethidium bromide. Moreover, apart from the
lmrCD upregulation, the cholate-resistant L. lactis strain (51)
showed a different gene expression profile from the strains
selected for resistance against cationic drugs (31). The cholate-
resistant strain also showed strong upregulation of the arc
operon genes involved in the arginine deiminase pathway and
of a gene encoding a putative MDR transporter of the MFS,
i.e., llmg2513 (formerly named yxbD).
Cholate resistance is of particular interest as lactic acid bac-
teria like Lactobacillus are important constituents of the hu-
man intestinal microflora and are widely used as probiotics in
food supplements (22, 42, 50). Probiotic survival depends on
resistance against inhibitory compounds present in the intes-
tine such as bile acids (29). These compounds are synthesized
from cholesterol in the liver and have an important role in the
intestine, where they are involved in the absorption of dietary
fats and lipid soluble vitamins (43). Bile acids are released as
conjugates of glycine or taurine in the intestine, where indig-
enous microbes such as Bifidobacteria employ bile acid hydro-
lases that enzymatically liberate the free bile acids (FBA) from
their conjugated forms (45). FBA are toxic, weakly acidic, and
hydrophobic molecules that strongly inhibit the growth of var-
ious intestinal bacteria (6). Cholate, which is one of the most
frequently encountered FBA in the gastrointestinal tract, is
produced by the gut microflora from conjugated bile salts, such
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as taurocholate and glycocholate (29). The exact mechanism of
inhibition is still not clear but may involve permeabilization of
the cytoplasmic membrane (28). The autochthonous micro-
biota as well as many gram-negative pathogens have evolved to
survive the bactericidal effects of FBA (49). The mechanisms
underlying bile acid resistance have been attributed to diverse
physiological and cellular responses such as changes in cell
envelope (11) and increased activity of bile acid modifying
enzymes in many gram-positive bacteria (4) while MDR efflux
pumps have been implicated in gram-negative bacteria (35). In
contrast, little is known about the role of MDR efflux pumps in
bile acid extrusion in gram-positive organisms.
Here, we have investigated the adaptive response of L. lactis
cells that lack the major MDR transporter, LmrCD, when
challenged with cholate. The data suggest that in the absence
of LmrCD, cholate resistance relies on a multitude of trans-
port-unrelated cellular responses. This investigation also es-
tablishes for the first time that LmrCD-mediated extrusion of
cholate is the primary mechanism of bile acid resistance in L.
lactis.
MATERIALS AND METHODS
Bacterial strains, medium, and growth conditions. L. lactis NZ9000 is a de-
rivative of the plasmid-free L. lactis MG1363 strain containing pepN::nisRK (13,
14) and is referred to as the wild-type strain. The derivative L. lactis NZ9000
lmrCD strain lacks the MDR transporter LmrCD (31). In all cases, cells were
grown at 30°C in M17 medium (Difco) containing 0.5% (wt/vol) glucose (GM17).
Cholate adaptation assay. Cholate-resistant cells were selected by growth of
the L. lactis NZ9000 lmrCD strain in GM17 medium containing increasing
concentrations of cholate. Exponentially growing cells were diluted 1:100 in 5 ml
of fresh GM17 containing cholate and grown overnight. This procedure was
repeated several times with a concomitant stepwise increase of the cholate
concentration until a significant increase in MIC had occurred. The final con-
centration of cholate used was 4 mM. To obtain single colonies, the adapted
culture was spread-plated on GM17 medium with 1.8% (wt/vol) agar containing
3 mM cholate. Thirty colonies were selected and subcultured in fresh GM17
broth without cholate. Cultures were supplemented with glycerol at a final
concentration of 10% (vol/vol) and stored at 80°C. Growth analysis of the
individual colonies indicated essentially identical 50% inhibitory concentrations
(IC50s) and MICs for cholate. One of the obtained cholate-adapted NZ9000
lmrCD colonies was selected and used for further characterization and is
referred to as the LmrCDr strain.
Growth studies. Overnight cultures of L. lactis wild-type, lmrCD and
LmrCDr strains were diluted in fresh GM17 medium and grown to an optical
density at 600 nm (OD660) of 0.6. In the case of strains bearing a plasmid, the
GM17 medium was supplemented with chloramphenicol at a final concentration
of 5 g/ml. Cells were then diluted to an OD660 of 0.05, and aliquots of 150 l
were transferred to 96-well microtiter plates that contained 50 l of GM17
medium containing a range of drugs at various concentrations. Sterile silicon oil
(50 l) was pipetted on top of the samples to prevent evaporation. Growth was
monitored at 30°C every 6 min for 8 to 12 h at 660 nm using a multiscan
photometer (spectraMax 340; Molecular Devices). The maximum specific growth
rate  was calculated from the exponential growth phase (52) and plotted against
the concentration of the different drugs. Concentrations that inhibited growth by
50% (IC50s) and 100% (MIC) were determined. The experiments were carried
out in triplicate, and the data shown are averaged to obtain the standard error of
the mean.
Cholate transport assay. Exponentially growing cells were harvested at an
OD660 of 1, washed once with 50 mM potassium phosphate (KPi), pH 7.0,
containing 1 mM MgSO4, and resuspended in this buffer to an OD660 of 20.
The cells were de-energized by incubation with 10 mM 2-deoxyglucose for 30 min
at 30°C, washed three times with KPi buffer, and finally resuspended in this buffer
to an OD660 of 8. Aliquots (3 ml) of the cell suspension were dispensed in glass
tubes and preincubated for 5 min at 30°C with gentle stirring. Next, 8 l of 1.82
mM [14C]cholate (55 mCi/mmol) was mixed with 4 l of 500 mM nonradioactive
cholate in 1 ml of MilliQ water, and 150 l of the mix was added to the cells (final
cholate concentration is 100 M), followed by incubation for 14 min after
which glucose (230 mM) was added as a source of metabolic energy. At the time
points indicated in the figures, the amount of [14C]cholate associated with cells
was determined by a filtration method. Herein, aliquots of 200 l were passed
over 0.2-m-pore-size cellulose-acetate filters that were prewetted in 100 mM
KPi, pH 7.0. Retained cells were then washed two times with 2 ml of 100 mM
LiCl. Finally, the radioactivity associated with the cells on the filter was measured
by liquid scintillation counting. Values were corrected for the background level
of radioactivity obtained for control incubations without cells. The amount of
accumulated cholate was related to the quantity of cells. Due to morphological
differences (see results) the cellular dry weight rather than the OD660 was used.
A similar experiment was performed using an L. lactis NZ9000 lmrCD strain
carrying the pILlmrCD plasmid (lmrCD expression under the control of native
promoter) and control plasmid pIL252 (31).
Scanning electron microscopy. A drop of a bacterial culture was placed on a
freshly cleaved mica surface pretreated with a 0.5% poly-L-lysine solution. Next,
cells were washed with 0.1 M cacodylate buffer, fixed with 2% glutaraldehyde in
0.1 M cacodylate buffer (pH 7.4) for 30 min, and washed with the cacodylate
buffer. The specimen was dehydrated with ethanol in a sequence of 30, 50, 70,
and 100% (10 min each), followed by two times in 100% for 30 min. Finally, the
specimen was dried in a Bal-Tec Critical Point Dryer with CO2 and sputter-
coated with 2 to 3 nm of Au/Pd (Bal-Tec sputter coater). Observation was done
with a Jeol FE-SEM 6301F (cold-field emission scanning electron microscope).
Expression analysis by RT-PCR. Overnight cultures of L. lactis NZ9000 were
diluted in GM17 medium to an OD660 of 0.05 and grown at 30°C until they
reached an OD660 of 0.6. Cholate (1 mM) was added to the cultures, and at
various time points, aliquots were removed, and cells were harvested by centrif-
ugation (3,500 rpm at 4°C for 5 min). Total RNA was isolated using TRIzol
reagent (Invitrogen). The RNA concentration was determined, and equal
amounts of RNA were transferred into Illustra Ready To-Go reverse transcrip-
tion-PCR (RT-PCR) tubes to generate cDNA from the RNA templates. The first
synthesis of a cDNA strand was performed at 42°C for 40 min, followed by
standard PCR conditions. RT-PCR products of the lmrC, lmrD, and secY genes
were obtained with gene-specific primer pairs (Table 1), and samples were
analyzed on a 2% (wt/vol) agarose gel.
DNA microarray analysis. DNA microarray experiments were essentially per-
formed as described previously (14, 47). In brief, RNA was isolated from
two replicate cultures of both L. lactis lmrCD and cholate-adapted L. lactis
LmrCDr. Cultures were grown at 30°C in GM17 medium in the absence of
cholate, and cells were harvested at an OD660 of 1. Next, single-strand RT
(amplification) and indirect labeling of 20 g of total RNA, with either Cy3 or
Cy5 dye, were performed (including samples in which the dyes were swapped to
correct for dye-specific effects). Labeled cDNA samples were hybridized to
microarray slides containing probes representing 2,496 open reading frames
(ORFs) of L. lactis MG1363 spotted in duplicate. After overnight hybridization,
slides were washed for 5 min at 37°C in 2 SSC (1 SSC is 0.15 M NaCl plus
0.015 M sodium citrate) containing 0.5% sodium dodecyl sulfate followed by 5
min in 1 SSC containing 0.25% sodium dodecyl sulfate to remove nonspecifi-
cally hybridized cDNAs. Slides were scanned using a GenePix 4200AL instru-
ment (Westburg). Subsequently, individual spot intensities were determined
using ArrayPro, version 4.5 (Media Cybernetics Inc., Silver Spring, MD). Slide
data were processed and normalized using MicroPrep, which yielded average
gene expression ratios of the mutant to the control strain. Expression of a gene
was considered to be significantly altered at a Cyber-T Bayesian P value of
0.001. From the set of genes that exhibited a significant change in expression,
only genes that exhibited a strong, i.e., 1.8-fold, change in expression are
discussed.
TABLE 1. Oligonucleotide primers used for RT-PCR analysis











a FW, forward; RV, reverse.
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Microarray data accession number. The array data reported in this publica-
tion have been deposited in the NCBI Gene Expression Omnibus (GEO; http:
//www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series accession
number GSE10203.
RESULTS
L. lactis can acquire resistance to cholate in the absence of
LmrCD. Previously, we have demonstrated that L. lactis cells
lacking the genes encoding the heterodimeric ABC-type MDR
transporter LmrCD become about twofold more susceptible to
cholate than wild-type cells (31). Transcriptome analysis of the
MDR strain of L. lactis selected for cholate resistance showed,
among other things, a marked induction of lmrCD expression
(31) that could be related to inactivation of the transcriptional
regulator LmrR (1). These data suggest an important role of
LmrCD in resistance to cholate but do not exclude an involve-
ment of other transporters or non-efflux-based mechanisms in
cholate resistance. Therefore, the cholate-sensitive L. lactis
lmrCD strain was repeatedly exposed to stepwise increasing
sublethal concentrations of cholate to induce resistance. In this
manner a strain with significantly improved resistance to
cholate was obtained (LmrCDr) (Fig. 1A and Table 2). The
observed phenotype was found to be stable as the LmrCDr
strain remained resistant after growth for 7 days in the absence
of cholate (data not shown). Cholate-adapted LmrCDrcells
were found to be 1.7-fold more resistant to cholate than the
parental lmrCD strain, as judged from the MICs (1.7 and 1
mM, respectively). However, in the absence of cholate, the
LmrCDr cells showed a lower growth rate than parental and
wild-type L. lactis cells. For reasons that remain unclear, the
IC50 of cholate obtained for the lmrCD strain was 2.5-fold
lower than that reported previously (1 and 2.5 mM, respec-
tively) (25). However, these IC50s were found consistently in at
least six independent experiments, while the relative resistance
levels between the wild-type and lmrCD strains obtained in
both studies were very similar. Plasmid-based overexpression
of lmrCD in the lmrCD strain increased cholate resistance up
to approximately fourfold (Fig. 1B), which greatly exceeded
FIG. 1. Bile acid resistance of L. lactis cells harboring or lacking the lmrCD genes. (A) Cholate resistance of L. lactis wild-type (), lmrCD
(‚), and LmrCDr (Œ) strains. (B) Cholate resistance of L. lactis lmrCD (E) and lmrCD containing plasmid pILlmrCD (F) or control plasmid
pIL252 (‚). (C) Cholate resistance of cholate-adapted LmrCDr cells containing pILlmrCD (‚) or pIL252 (Œ). (D) Glycodeoxycholate resistance
of LmrCDr cells containing pILlmrCD (f) or pIL252 (). Note that the plasmid-encoded lmrCD genes are under the control of their native
promoter. Cells were grown for 8 h in GM17 medium in the absence or presence of various concentrations of bile acid, and the maximum specific
growth rate, , was determined.
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the cholate resistance level of both the LmrCDr and the
wild-type strain (Fig. 1A and B). Overall, these data demon-
strate that LmrCD provides resistance to cholate.
Exposure to one specific drug may evoke cross-resistance to
other toxic compounds in bacteria (18, 41). Therefore, the
resistance to structurally and functionally diverse toxic com-
pounds was determined. To this end, LmrCDr cells were
grown in the presence of a variety of drugs, among which a
range of bile acids, several commonly used antibiotics, and
structurally unrelated fluorescent dyes like rhodamine 6G,
ethidium bromide, and Hoechst 33342 (Table 2). Compared to
the wild-type cells, L. lactis lmrCD cells proved to be suscep-
tible to glycodeoxycholate in addition to cholate, Hoechst
33342, daunomycin, rhodamine 6G, and ethidium bromide. Com-
pared to the lmrCD strain, the cholate-adapted LmrCDr cells
showed a significant increase in resistance to the unconjugated
bile acids deoxycholate (1.6-fold) and chenodeoxycholate (1.5-
fold) and the glycoconjugate of deoxycholate (1.5-fold). Inter-
estingly, the acquired resistance to several of these cholate
derivatives even exceeded that of the wild-type cells. However,
this was certainly not the case for glycodeoxycholate. Com-
pared to the wild-type strain, LmrCDr cells were 4.2-fold
more susceptible to glycodeoxycholate (Table 2). Note that the
deletion of the lmrCD genes from the wild-type strain results in
a more than sixfold increase in sensitivity to glycodeoxycholate
(Table 2.). These data suggest that glycodeoxycholate is an
important substrate for LmrCD.
In contrast to the observed enhanced resistance to bile acids,
LmrCDr cells did not show a significant improvement in
resistance to any of the antibiotics and fluorescent dyes tested.
On the other hand, the LmrCDr strain was twofold more
susceptible to quinine than the lmrCD and wild-type strains.
Taken together, the results indicate that the acquired resis-
tance of the LmrCDr strain does not arise from MDR but is
specific for cholate and related bile acids.
Next, we tested whether the resistance to bile acids of the
LmrCDr strain could be enhanced by reintroducing the
lmrCD genes. The LmrCDr strain carrying either the control
plasmid or the plasmid harboring the lmrCD genes (under the
control of their own promoter) was grown in the presence of
cholate (Fig. 1C) or glycodeoxycholate (Fig. 1D). Expression
of lmrCD in LmrCDr cells resulted in a relatively small in-
crease in cholate resistance, i.e., the IC50 increased from 2.4 to
3.2 mM (Fig. 1C). For glycodeoxycholate (Fig. 1D), the IC50
essentially did not change upon expression of lmrCD (i.e., it
remained at 1.5 mM). In contrast, the MICs, differed greatly;
LmrCDr cells readily die in the presence of 2.4 mM glycode-
oxycholate, but when expressing LmrCD they can withstand
concentrations up to 8 mM (Fig. 1D), which is consistent with
the notion that glycodeoxycholate is an excellent substrate for
LmrCD. The LmrCDr strain carrying the lmrCD plasmid was
also grown in the presence of ethidium bromide, rhodamine
6G, or Hoechst 33342. As expected, the LmrCDr strain
gained the MDR phenotype associated with LmrCD expres-
sion (data not shown).
During growth L. lactis produces lactic acid, which results in
acidification of the growth medium (40). Since the pH may
affect the solubility (and, thus, toxicity) of the bile acids tested,
the acidification of the growth medium caused by the wild-
type, lmrCD, and LmrCDr strains, either in the absence or
presence of cholate (0.7 mM and 2.2 mM), was monitored in
time (data not shown). All strains showed similar degrees of
acidification with a drop of the pH from pH 7.3 at the early
stages of growth to pH 5.4 in the stationary growth phase. This
shows that the bile acid resistance of the LmrCDr strain is not
due to alteration in primary metabolism.
Cholate-adapted L. lactis lmrCD cells exhibit an altered
cell morphology. In the absence of drugs, LmrCDr cells had
a slower growth rate than the parental lmrCD and wild-type
strains (Fig. 1A and 3). Interestingly, LmrCDr cells exhibited
an unusual flaky morphology when cultivated in GM17 me-
dium, and they sedimented more readily than lmrCD and
wild-type cells. Scanning electron microscopy revealed that
LmrCDr cells were similar in size to the lmrCD and wild-
type cells but appeared to grow in unusually long strings of
cocci clumped together as large aggregates (Fig. 2). Although
multiplication of the LmrCDr cells seemed unaffected, the
final stage of cell division, i.e., cell separation, was clearly
impaired. Such an altered overall cellular morphology likely
results from changes in the cell envelope.
To investigate the latter possibility, the sensitivity of the cells
to various bacteriocins was tested. This included peptides that
specifically act on the cell membrane either by a combination
of pore formation and inhibition of peptidoglycan synthesis
(nisin) or by exclusively inhibiting peptidoglycan synthesis
(bacitracin and vancomycin) (Fig. 3). Wild-type and lmrCD
cells displayed very similar sensitivities to the tested bacterio-
cins. In contrast, LmrCDr cells were found to be highly sus-
ceptible to the bacteriocin nisin (fourfold lower IC50), while
improved resistance to bacitracin (twofold higher IC50) was
observed. The sensitivity to vancomycin was similar to that of
the control strains. The altered sensitivity of LmrCDr cells to
membrane- and peptidoglycan-acting compounds likely arises
from an altered cell envelope. Such altered properties of the
TABLE 2. Susceptibility of L. lactis wild-type, lmrCD, and
LmrCDr strains to various bile acids and drugs
Drug
IC50 (M) of the indicated straina Relative
resistancefWild type lmrCD LmrCDr
Lithocholatec 85 85 80 0.9
Deoxycholateb,d 125  15 120  18 190  18 1.6
Chenodeoxycholateb,d 115 105 160 1.5
Cholateb,e 1650  273 1000  146 1650  261 1.7
Glycodeoxycholateb 6800  566 1063  53 1625  35 1.5
Taurocholateb NS NS NS
Glycocholateb NS NS NS
Hoechst 33342 1.55  0.13 0.3  0.21 0.35  0.17 1.2
Daunomycin 25.5 2.8 2.8 1.0
Rhodamine 6G 5.7 4.9 4.5 0.9
Ethidium bromide 4.8 3.7 3.4 0.9
Quinine 850 775 350 0.5
Tetracycline 0.26 0.2 0.18 0.9
Erythromycin 0.065 0.067 0.061 0.9
Kanamycin 35  9 33  9.5 41  6.8 1.2
Chloramphenicol 4.0  0.5 4.2  0.9 4.5  0.6 1.1
Puromycin 27.5 26.5 27 1.0
a Values are means and standard errors of IC50s obtained from at least three
independent experiments. NS, not sensitive (no appreciable growth inhibition at
6 mM).
b Sodium salts (anionic detergent).
c One hydroxyl group.
d Two hydroxyl groups.
e Three hydroxyl groups.
f Calculated as (IC50 of LmrCDr cells)/(IC50 of lmrCD cells).
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cell surface may also account for the increased susceptibility to
quinine (Table 2).
Transcriptome analysis of cholate-adapted L. lactis lmrCD
cells. To investigate the underlying adaptive mechanism(s) of
the cholate-adapted strain, DNA microarray analysis was per-
formed on the global gene expression profiles of exponentially
growing lmrCD and LmrCDr cells in the absence of cholate.
Compared to the parental lmrCD strain, 124 genes of the
LmrCDr strain showed 1.8-fold change in expression with a
Bayesian P value of 0.001 (the full array data set is available
under accession number GSE10203 at http://www.ncbi.nlm.nih
.gov/geo/accessible). Of these genes, 87 and 37 showed an
increased and decreased expression, respectively. The maxi-
mum level of gene induction and repression was 5-fold (matR)
and 11.6-fold (llmg1356), respectively. The differentially ex-
pressed genes were grouped into functional classes (Table 3),
taking into account the categories defined earlier for the re-
lated L. lactis strain IL1403 (9). Responsive genes were related
to cell envelope biogenesis, stress response and chaperones,
general metabolism, housekeeping functions, and sex factor.
Remarkably, the expression of none of the 40 genes encoding
putative MDR transporters, among which are the well-charac-
terized LmrA and LmrP, was significantly altered in the
LmrCDr strain. This also includes the llmg2513 (yxbD) gene
that was upregulated in the MDR strain of L. lactis selected by
cholate (31). Expression of a large number of hypothetical
ORFs was also significantly changed including llmg1960, a
putative di- and tricarboxylate transporter. However, none of
the remaining upregulated hypothetical ORFs could be related
to a (drug) transport function (see full array set).
Genes related to cell envelope. Various genes associated
with cell envelope biosynthesis or morphology, namely, cdsA,
murC, rgpE, llmg0215, llmg0538, and llmg1148, showed in-
creased expression levels in the LmrCDr strain. Decreased
expression levels were observed for cfa, which is involved in
membrane lipid biosynthesis, and mvk, a key gene of the me-
valonate biosynthetic pathway needed for isoprenoid synthesis.
Genes related to stress response and chaperones. A distinct
level of overexpression of the molecular chaperone genes
groES, groEL, and hslO was observed in the LmrCDr strain,
as well the gene encoding a serine protease, htrA, implicated in
protein folding stress. Also nah, encoding an Na/H anti-
porter involved in sodium toxicity and intracellular pH regu-
lation, was expressed at a higher level. In contrast, oxidative
stress response genes trxA, sodA, and gshR and the general
FIG. 2. Morphological changes in L. lactis lmrCD cells following cholate adaptation. Scanning electron micrographs of LmrCDr cells at
magnifications of 6,000 (A) or 45,000 (B) and of the parental lmrCD strain at a magnification of 45,000 (C). Bars, 1 m (A) and 100 nm
(B and C).
FIG. 3. Sensitivity of L. lactis wild-type (), lmrCD (‚), and
the cholate-adapted LmrCDr (Œ) strain to bacteriocins. Cells were
grown for 8 h in GM17 medium containing the bacteriocins baci-
tracin (A), vancomycin (B), or nisin (C) at various concentrations.
The maximum specific growth rate, , is plotted against the bacte-
riocin concentration.
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TABLE 3. Differential expression of genes in cholate-adapted L. lactis LmrCDr cells versus lmrCD cells
Functional class and
gene name Bayesian P value Fold change Proposed name and/or description
Sex factor/conjugation
matR 1.38E-10 5.0 Retron-type reverse transcriptase/LtrA
cluA 2.73E-09 3.2 Cell surface antigen I/II precursor
llmg1399 8.14E-09 3.2 Putative cell surface antigen
ltrC 7.05E-08 2.7 Relaxosome formation
ltrB 1.51E-06 2.5 Group II intron-interrupted relaxase LtrB (mobA)
ltrD 5.47E-07 2.4 Relaxosome formation
ltrE 1.46E-06 2.0 Relaxosome formation
traD 5.81E-06 1.8 Conjugal transfer protein TraD
llmg1353 6.39E-11 11.0 Putative tellurite resistance protein
telB 1.73E-13 10.8 Putative tellurite resistance protein
telC 5.43E-11 7.1 Putative tellurite resistance protein
telA 1.32E-10 6.6 Putative tellurite resistance protein
Stress and chaperones
groES 7.77E-09 2.9 GroES/Hsp10 chaperone
nah 3.96E-09 2.8 Na/H antiporter
htrA 4.91E-08 2.7 Housekeeping protease
groEL 2.83E-08 2.5 GroEL/Hsp60 chaperone
hslO 5.55E-08 2.4 Heat shock protein; 33-kDa chaperone
llmg2047 1.51E-08 2.8 Universal stress protein E
uspA2 2.67E-06 2.1 Universal stress protein A2
uspA 2.02E-07 2.1 Universal stress protein A
sodA 1.32E-07 2.1 Superoxide dismutase
clpE 6.57E-07 2.0 ATP-dependent Clp protease ATP-binding subunit E
gshR 5.95E-07 2.0 Glutathione reductase
trxA 3.66E-07 1.9 Thioredoxin
Cell envelope
chiC 8.22E-09 2.8 Acidic endochitinase precursor
llmg1148 1.65E-07 2.5 Putative cell surface antigen
llmg2420 1.24E-07 2.3 Putative glycosyltransferase
chb 2.43E-07 2.2 Chitin binding protein, putative
cdsA 7.95E-07 2.1 Phosphatidate cytidylyltransferase
llmg0538 4.95E-07 2.0 (3R)-Hydroxymyristoyl-(acyl-carrier-protein) dehydratase
lplL 1.29E-05 1.9 Lipoate-protein ligase A
murC 1.93E-04 1.9 UDP-N-acetyl muramate-alanine ligase
llmg2421 1.67E-05 1.9 Putative glycosyltransferase
llmg0215 6.65E-04 1.8 Predicted membrane protein
rgpE 2.80E-04 1.8 Glycosyltransferase RgpE
cfa 1.82E-06 2.0 Cyclopropane-fatty-acyl-phospholipid synthase
mvk 7.80E-07 2.0 Mevalonate kinase
apbE 1.82E-06 1.9 Thiamine biosynthesis lipoprotein ApbE precursor
General metabolism
rrma 5.78E-09 3.1 Putative rRNA (guanine-N1-)-methyltransferase
gltX 3.69E-06 2.6 Glutamyl-tRNA synthetase
llmg1361 8.96E-06 2.6 Putative tyrosine recombinase
polC 4.66E-05 2.2 DNA polymerase III alpha subunit
ackA1 5.52E-07 2.1 AckA1 protein (Acetate kinase)
lacX 5.87E-07 2.1 Galactose mutarotase related enzyme
purA 8.09E-07 2.1 Putative adenylosuccinate synthetase
hisS 4.30E-08 2.0 Histidyl-tRNA synthetase, class IIa
llmg1089 1.49E-06 2.0 Carbamoyl-phosphate synthase, large subunit
ilvB 6.31E-05 2.0 Acetolactate synthase large subunit
butA 6.56E-08 2.0 Acetoin reductase
llmg2209 4.46E-07 1.9 tRNA-dihydrouridine synthase B
pheS 2.84E-06 1.9 Phenylalanyl-tRNA synthetase alpha chain
pfl 9.71E-06 1.9 Pyruvate formate lyase
recF 3.12E-06 1.9 DNA replication and repair protein RecF
proS 2.16E-06 1.8 Prolyl-tRNA synthetase
llmg2205 5.25E-06 1.8 Conserved hypothetical protein
polA 2.84E-06 1.8 DNA polymerase I
metA 1.32E-06 1.8 Homoserine O-succinyltransferase
glmS 7.67E-09 2.7 Glucosamine-fructose-6-phosphate aminotransferase
add 2.59E-06 2.6 Adenosine deaminase
ilvE 5.20E-04 2.2 Branched-chain amino acid aminotransferase
rlrG 8.25E-07 2.2 Transcriptional regulator, LysR family
pepC 4.72E-06 2.1 Aminopeptidase C
serB 2.74E-06 2.0 Phosphoserine phosphatase
llmg1086 1.91E-06 1.9 MgtA-like cation transporting ATPase
nadE 5.04E-06 1.9 NAD synthase
cysD 1.70E-06 1.9 O-acetylhomoserine sulfhydrylase
fbaA 8.76E-07 1.8 Fructose-bisphosphate aldolase
dtpT 2.09E-06 1.8 Di-/tripeptide transporter
a Statistically significant changes in expression are given as the ratio of the cholate-adapted LmrCDr strain versus the control lmrCD strain (fold change). For
clarity, most hypothetical ORFs (56) were omitted.
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stress response genes uspA and uspA2 were distinctly re-
pressed.
Genes related to general metabolism and housekeeping
functions. A variety of genes related to various biosynthetic
pathways and DNA replication and repair are differentially
expressed. Increases in expression of the genes rrma, polC,
polA, and recF involved in DNA replication occurred in the
LmrCDr strain. Likewise, an increase in expression of genes
involved in amino acid biosynthesis (i.e., ilvB, metA, proS,
llmg1089, hisS, gltX, and pheS) and sugar metabolism (i.e.,
lacX, ackA1, pfl, and butA) was observed, whereas several
other genes were repressed, such as serB and cysD involved in
glycine and serine biosynthesis, respectively, as well as genes
involved in nucleotide biosynthesis. Of the extensive proteo-
lytic system of L. lactis, only pepC, an amino acid peptidase,
and dtpT, a di- and tripeptide transporter, exhibited significant
repression.
Sex factor. The sex factor is a chromosomally located
55-kb element (llmg1411-llmg1348) involved in conjugation.
Forty-one out of 57 sex factor genes were significantly differ-
entially expressed. One of the most prominently upregulated
genes is cluA. This gene confers a cell aggregation phenotype
in L. lactis (34), which would explain the clumping phenotype
observed. A similar role for the product of llmg1399 can be
envisaged as it lies in close proximity to cluA and shares high
homology with it. In addition, traD, involved in conjugal trans-
fer, was distinctly overexpressed. A group of 10 genes located
at the distal end of the element is significantly repressed.
Among these, telA, telB, and telC have been implicated in
tellurite resistance. In line with this observation, the LmrCDr
cells were found to be significantly more susceptible to tellurite
than cells of the lmrCD and wild-type strains, with MICs of
1.5, 2.5, and 2.5 mM, respectively (data not shown).
LmrCD is responsible for cholate extrusion. The transcrip-
tome analysis of the cholate-adapted LmrCDr cells showed
no evidence of an altered expression of any of the putative
MDR transporters. To further analyze the mechanism of
cholate resistance, the ability of cholate to enter cells was
examined by means of a [14C]cholate transport assay. Wild-
type, lmrCD, and LmrCDr cells showed a similar level of
[14C]cholate association when tested under energy-deprived
conditions (Fig. 4A). Upon the addition of glucose, lmrCD
cells accumulated cholate in a time-dependent fashion, while
wild-type cells showed a strong extrusion of cholate under
identical conditions. For energized LmrCDr cells, initially a
minor efflux is observed, followed by an extended cholate ac-
cumulation phase similar to that of the lmrCD strain. The
LmrCDr cells accumulated cholate to a lesser extent (approx-
imately twofold) than the parental lmrCD strain. The cholate
extrusion activity of L. lactis lmrCD cells could be restored by
the reintroduction of the lmrCD genes on a plasmid under the
control of their native promoter (Fig. 4B). It should be noted
that since cholate is a weak acid, the observed energy-depen-
dent uptake of cholate by the lmrCD and LmrCDr cells
(Fig. 4A) likely results from passive permeation and a pH-
dependent partitioning of the cholate across the membrane.
Taken together, these data unequivocally show that in L. lactis,
LmrCD efficiently extrudes cholate from the cell in an energy-
dependent fashion. Furthermore, the apparent lack of major
extrusion activity in the LmrCDr cells suggests that LmrCD is
the major contributor in cholate extrusion and lends further sup-
port for the notion that the cholate resistance of the LmrCDr
strain is unrelated to a transport phenomenon.
The expression of the lmrCD genes in L. lactis is controlled
by the transcriptional regulator LmrR (1). Previous studies
have demonstrated that binding of drugs like Hoechst 33342
and daunomycin to LmrR relieves the repression of the lmrCD
genes, thus leading to the manifestation of the MDR pheno-
type. Since growth and transport studies suggest that bile acids
are natural substrates of the LmrCD transporter, the ability of
cholate to induce the expression of the lmrCD genes was in-
vestigated. RT-PCR-based detection of mRNA revealed a
transient increase of both the lmrC and lmrD transcripts upon
a challenge of the cells with cholate (Fig. 5). On the other
hand, the mRNA levels of the constitutively expressed secY
gene remained unaltered. This indicates that cholate is an
inducer of lmrCD expression.
DISCUSSION
The most widely used probiotic bacteria are Lactobacillus
and Bifidobacteria, which are natural inhabitants of the human
gastrointestinal tract. Lactococci are not considered part of the
gastrointestinal tract, and only a few studies on their probiotic
activity are available. However, lactococci do exhibit probiotic
properties, like the ability to (i) survive in the gut, (ii) lower the
cholesterol level, and (iii) modulate the immune response of
the host (26, 46). Lactococci also tolerate gut secretions such as
FIG. 4. Accumulation of cholate by L. lactis cells harboring or
lacking lmrCD genes. (A and B) De-energized cells were preloaded
with [14C]cholate, and after 14 min cells were energized with glucose at
a final concentration of 230 mM. The arrow indicates when glucose
was added. (A) Cholate accumulation in the wild-type (), lmrCD
(‚), and LmrCDr (Œ) strains. (B) Cholate accumulation in the lmrCD
strain containing plasmid pILlmrCD (f) or pIL252 (‚).
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bile acids (24, 25). The purpose of this study was to examine
the role of the ABC-type MDR transporter LmrCD in bile acid
resistance. In gram-negative bacteria, drug extrusion-based
mechanisms across the outer membrane are major determi-
nants of bile acid resistance. This resistance involves MDR
efflux pumps that belong to resistance nodulation division and
MFS (30, 38), both of which utilize the proton motive force as
an energy source. In gram-positive bacteria such as L. lactis,
the exact mechanisms of cholate resistance are less clear, but
the involvement of efflux-based mechanisms based on second-
ary transport have been suggested (20).
Here, we demonstrate that in L. lactis, LmrCD is responsible
for an extrusion-based mechanism of resistance against cholate
and also provides resistance against the physiologically rele-
vant conjugate glycodeoxycholate. Cells lacking the lmrCD
genes are sensitive to these compounds. However, when chal-
lenged with increasing concentrations of cholate, these cells
regain resistance. Remarkably, this resistance is no longer
based on an extrusion mechanism but relates to secondary
responses such as cell envelope changes, stress responses, and
alterations in metabolism. On the other hand, in wild-type cells
the short-term response to a challenge with cholate is the
upregulation of the lmrCD genes, resulting in an increased
extrusion of cholate. This upregulation involves the transcrip-
tional repressor LmrR that likely interacts directly with
cholate, whereupon repression of lmrCD is relieved (1). To our
knowledge, this report shows for the first time a central role of
an ABC-type transporter in bile acid resistance in prokaryotes.
In this respect, ABC-type transporters are generally involved
in bile extrusion and transport within the liver (15).
To investigate possible alternative mechanisms of cholate
resistance, the cholate-adapted strain, LmrCDr, and parental
strain were subjected to transcriptome profiling. About 100
genes involved in cellular metabolism and morphology were
found to be differentially expressed in the transcriptome of the
cholate-adapted strain. This is in sharp contrast to what was
observed in cholate-adapted wild-type L. lactis cells, which
showed a prominent defect in the lmrR gene that encodes a
transcriptional repressor of lmrCD expression, which resulted
in the constitutive expression of the lmrCD genes (1, 32).
Interestingly, neither the well-characterized transporters
LmrA and LmrP nor any of the other remaining putative MDR
transporters were found to be upregulated in the cholate-
adapted LmrCDr strain, lending further support to the notion
that bile acid extrusion is a key activity of LmrCD.
One of the most strongly induced genes in LmrCDr cells is
nah, which encodes the Na/H antiporter that has been im-
plicated in intracellular pH homeostasis and Na toxicity. Due
to passive permeation of cholic acid, high concentrations of
cholate might interfere with intracellular pH regulation, which
may explain this cellular response. Alternatively, upregulation
of nah is a means to counteract Na toxicity as cholate is added
as a sodium salt. One of the other remarkable responses is the
upregulation of the genes associated with the chromosomally
embedded sex factor. This 55-kb region comprises a unique
mobile genetic element in L. lactis that can be excised in a
closed circular form and is readily lost from cells (17). The
genes contained in the proximal region (ltrA-matR, ltrB, ltrC,
ltrD, ltrE, and traD) show strongly elevated expression. ltrA-
matR codes for a protein with reverse transcriptase, endonu-
clease, and RNA maturase activity (37) that facilitates retro-
homing of ltrB into intronless alleles. The ltrC, ltrD, and ltrE
gene products are involved in relaxosome formation during
conjugation (12) while traD encodes a coupling protein that
links to the DNA transfer intermediate and perhaps leads the
DNA through the mating channel (19). It has been shown for
L. lactis MG1363 that the sex factor element can mobilize
chromosomal genes (16). Possibly during cholate stress, ge-
netic traits that confer resistance to cholate may be transferred
to the recipient cells. Another sex factor gene, cluA, associated
with cell aggregation phenotype also increased in expression
and is involved in the cell-to-cell contact necessary for conjugal
transfer (44). CluA is a 136-kDa surface-bound protein co-
valently linked to the cell wall peptidoglycan. This protein is
not only responsible for a constitutive aggregation phenotype
in L. lactis MG1363 but also linked to high-frequency conju-
gation and transfer of the sex factor (34, 42). The upregulation
of the sex factor genes might thus be responsible for a major
morphological change such as the clumping of the cells that
may provide a certain level of protection to the inner cells in
the aggregate to cholate. Interestingly, Lactobacillus plantarum
also showed morphological changes in response to bile acid
stress (10). Challenged cells clumped together (but did not
form long strings) and showed elevated expression levels of
several genes involved in membrane- and cell wall-associated
functions. Thus, altering the properties of the bacterial cell
surface may be a common response to bile acid stress.
In the LmrCDr strain several upregulated genes appear to
be associated with cell envelope biogenesis such as murC,
which is involved in the biosynthesis of the peptidoglycan
murein, which catalyzes the addition of L-alanine to the nucle-
otide precursor UDP-N-acetylmuramoyl, and genes such as
rgpE, llmg2420, and llmg2421, encoding putative glycosyltrans-
ferases that catalyze the formation of linear glycan chains. The
upregulation of these genes may result in an alteration of the
cell envelope composition and thus indirectly affect cholate
permeation and susceptibility. This is further supported by the
altered responses of the cholate-adapted cells to the activity of
three peptide antibiotics, i.e., nisin, bacitracin, and vancomy-
cin. These antimicrobials affect the cell envelope by different
mechanisms of action (2, 3, 23). The increased nisin sensitivity
in the cholate-adapted strain suggests that either the levels of
lipid II, the binding site for nisin, have increased (2, 36) or that
FIG. 5. Cell-based RT-PCR analysis of lmrCD expression in L.
lactis wild-type cells following cholate induction. PCR products were
generated through the use of gene-specific primers for lmrCD. Ampli-
fied products were separated on 2.0% agarose gels and were identified
by ethidium bromide staining. For each time sample, an RT-PCR with
primers specific for the secY gene was run as a control.
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lipid II is more accessible (27, 36). Nisin sensitivity frequently
links to bacitracin resistance in bacteria (36), and this also
appears to be the case in the cholate-adapted strain. On the
other hand, the vancomycin sensitivity did not change, dem-
onstrating that vancomycin binding sites have not changed in
the mutant, thus suggesting that the different responses are
due to antimicrobial-dependent differences in cell envelope
permeation.
Although the cholate-adapted LmrCDr cells show a
greater resistance to bile acids than wild-type cells, this is not
the case for all derivatives tested (Table 2). The cholate-
adapted cells remained very susceptible to the hydrophobic
bile acid lithocholate and are substantially more sensitive to
glycodeoxycholate than the wild-type. Our data show that the
unconjugated bile acids (cholate, deoxycholate, chenodeoxy-
cholate, and lithocholate) are more toxic to L. lactis than the
conjugated forms (glycodeoxycholate, glycocholate, and tauro-
cholate) as is the case with bacteria in general (39). The lack of
toxicity of taurocholate and glycocholate may be due to the low
pKa values (1.4 and 2.4, respectively) which render these
compounds fully ionized at neutral pH. Thus, these molecules
are likely highly membrane impermeable. Overall, the suscep-
tibility of L. lactis for bile acids seems to be directly related to
their hydrophobicity. Indeed, membrane permeability de-
creases with the number of the hydroxyl group additions (28).
However, this assessment does not take into account the ex-
trusion-based resistance mechanism that prevails in wild-type
cells. Notably, the toxicity of glycodeoxycholate is strongly de-
pendent on the activity of LmrCD. This is intriguing since
glyco-forms of bile acid conjugates are more toxic than tauro-
conjugates while the former also represent the predominant
form of bile salt conjugate in human bile (5). Therefore, the
observation that LmrCD renders cells highly resistant to gly-
codeoxycholate suggests that bile acids are natural substrates
of this transporter. As homologs of LmrCD are widely distrib-
uted among gut bacteria, ABC-type MDR transporters may be
important factors in colonization and survival in the intestine.
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